Founded Year

2010

Stage

Series D | Alive

Total Raised

$102.5M

Last Raised

$30M | 1 yr ago

Mosaic Score

+10 points in the past 30 days

What is a Mosaic Score?
The Mosaic Score is an algorithm that measures the overall financial health and market potential of private companies.

About Glooko

Glooko's universal diabetes software products provide insights to improve outcomes for people with diabetes and their care teams. Glooko's systems synchronize data from more than 190 diabetes devices and activity trackers, and they deliver integrated, timely and useful patient data, including glucose levels, blood pressure, weight, and food, insulin and medication intake.

Glooko Headquarter Location

411 High St.

Palo Alto, California, 94301,

United States

650 720-5310

ESPs containing Glooko

The ESP matrix leverages data and analyst insight to identify and rank leading companies in a given technology landscape.

EXECUTION STRENGTHMARKET STRENGTHLEADERHIGHFLIEROUTPERFORMERCHALLENGER
Healthcare / Healthcare Providers

Digital therapeutics (DTx) vendors deliver evidence-based therapeutic interventions to patients that are driven by high-quality software programs to prevent, manage, or treat a medical disorder or disease. Diabetes DTx vendors provide digital diabetes prevention programs alongside diabetes chronic care management tools.

Glooko named as Leader among 8 other companies, including Omada Health, One Drop, and Fruit Street Health.

EXECUTION STRENGTHMARKET STRENGTHLEADERHIGHFLIEROUTPERFORMERCHALLENGER
Healthcare / Medical Devices

In medicine, wirelessly-connected devices can include small, portable exam tools, wearable ambulatory monitors, and large immobile pieces of medical equipment. Embedded sensors can collect data related to patient health as well as device use and performance.

Glooko named as Leader among 9 other companies, including Babyscripts, TytoCare, and AliveCor.

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Glooko's Products & Differentiation

See Glooko's products and how their products differentiate from alternatives and competitors

  • Glooko Enterprise

    High security RPM platform/patient app for managing chronic conditions fully integrated into health systems' EMR systems and payors population health systems

    Differentiation

    Device agnostic (hundreds of integrations with diabetes, fitness, blood pressure devices), full RPM capabilities, full EHR integration options 

  • Subscribe to see more

    We're on a mission to enable every organization to make smarter decisions about tech. Whether it's finding a new game-changing vendor or understanding a new market, it's easier, faster and smarter with CB Insights. All made possible by the smartest, hardest-working team in tech. Subscribe to see more.

    Differentiation

    We're on a mission to enable every organization to make smarter decisions about tech. Whether it's finding a new game-changing vendor or understanding a new market, it's easier, faster and smarter with CB Insights. All made possible by the smartest, hardest-working team in tech. Subscribe to see more.

  • Subscribe to see more

    We're on a mission to enable every organization to make smarter decisions about tech. Whether it's finding a new game-changing vendor or understanding a new market, it's easier, faster and smarter with CB Insights. All made possible by the smartest, hardest-working team in tech. Subscribe to see more.

    Differentiation

    We're on a mission to enable every organization to make smarter decisions about tech. Whether it's finding a new game-changing vendor or understanding a new market, it's easier, faster and smarter with CB Insights. All made possible by the smartest, hardest-working team in tech. Subscribe to see more.

Expert Collections containing Glooko

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Glooko is included in 8 Expert Collections, including Digital Health.

D

Digital Health

13,210 items

Companies developing and enabling evidence-based, software-driven therapeutic interventions to prevent, manage, or treat a medical disorder or disease. (*Scope follows the Digital Therapeutics Alliance definition)

D

Digital Health 150

150 items

2019's cohort of the most promising digital health startups transforming the healthcare industry

V

Value-Based Care & Population Health

866 items

The VBC & Population Health collection includes companies that enable and deliver care models that address the health needs for defining populations along the continuum of care, including in the community setting, through participation, engagement, and targeted interventions.

M

Medical Devices

11,412 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.

D

Diabetes

1,750 items

T

Telehealth

2,800 items

Companies developing, offering, or using electronic and telecommunication technologies to facilitate the delivery of health & wellness services from a distance. *Columns updated as regularly as possible; priority given to companies with the most and/or most recent funding.

Glooko Patents

Glooko has filed 4 patents.

The 3 most popular patent topics include:

  • Blood tests
  • Diabetes
  • Implants (medicine)
patents chart

Application Date

Grant Date

Title

Related Topics

Status

11/1/2016

8/6/2019

Diabetes, Insulin therapies, Sensors, Blood tests, Body fluids

Grant

Application Date

11/1/2016

Grant Date

8/6/2019

Title

Related Topics

Diabetes, Insulin therapies, Sensors, Blood tests, Body fluids

Status

Grant

Latest Glooko News

07:00 EDT Glooko Appoints Alfonso "Chito" Zulueta, former Eli Lilly & Company Senior Executive, to Board of Directors

Apr 27, 2022

News provided by Share this article Share this article PALO ALTO, Calif., April 27, 2022 /PRNewswire/ -- Glooko, Inc., a leading provider of remote patient monitoring and data management solutions for diabetes and related chronic conditions, today announced the appointment of Alfonso "Chito" Zulueta to its Board of Directors. Respected as a leader with a strong track record of success in the pharmaceutical industry and deep experience on corporate boards and industry associations, Mr. Zulueta comes to the Glooko Board having served as a senior executive leading a wide range of global business and commercial units over his more than 30-year career with Eli Lilly and Company. The Glooko leadership team and Board welcome the breadth and depth of experience he brings as the company continues its strategic growth as a digital health leader in chronic disease management. "We are very excited for Chito to join our Board and particularly fortunate for his strong understanding of the impact that digital health solutions can have on managing chronic diseases," said Russ Johannesson, CEO of Glooko. "He brings a wealth of valuable experience and unique perspectives to our Board, having led successful global healthcare ventures focused on treating diabetes and other diseases. Chito's appointment comes at a critical time for Glooko, as we continue to broaden our digital therapeutics (DTx) and clinical research businesses." Mr. Zulueta retired at the end of 2021 from his roles at Lilly as an executive committee member, corporate officer and president of the company's international business unit, where  he was responsible for leading Lilly's business in all geographies outside of the U.S. and Canada. Prior to that, he served as Lilly's president of its Emerging Market business unit, president of Japan, president of Global Oncology and Critical Care product group, vice president in charge of U.S. sales and marketing for the neuroscience and diabetes/family health business unit, and vice president of global marketing. "This is a compelling time to join the Glooko Board as the Company expands its offerings and commercial footprint," said Mr. Zulueta. "Glooko is rapidly increasing its market relevance and is driving real innovation through its digital health solutions, serving more patients and healthcare professionals globally. I'm excited to leverage my experience and insights to help Glooko accelerate this growth and evolution." Mr. Zulueta also serves on the boards of directors of CTS Corporate, Syneos Health, and Calidi Biotherapeutics, Inc. He served previously on the boards of industry associations, including the European Federation of Pharmaceutical Industries and Associations (chairman of the international committee), PhRMA (chairman of the Japan business executive committee), the American Chamber of Commerce of Japan (governor of the Kansai chapter), and the U.S.- Japan Business Council. Mr. Zulueta earned an MBA from the Darden School of Business Administration of the University of Virginia and a bachelor's degree in economics from De La Salle University. About Glooko Glooko is transforming digital health by connecting people with diabetes and related chronic conditions with their healthcare teams, enabling collaborative telehealth, clinical research and improved health outcomes. The company's software platforms collect and analyze data from multiple devices in one highly secure place, allowing for easy remote upload via app or in-clinic, and producing easy-to-read analytics through actionable charts and graphs. The platform is compatible with over 95% of global diabetes and health monitoring devices, giving patients and their providers flexibility in how to manage their conditions. With over 35 billion data points, Glooko is the global leader in diabetes patient data. Glooko's solutions can be found in 31 countries across 22 languages. Learn more at  glooko.com . Media Inquiries:

Glooko Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Glooko Rank

  • When was Glooko founded?

    Glooko was founded in 2010.

  • Where is Glooko's headquarters?

    Glooko's headquarters is located at 411 High St., Palo Alto.

  • What is Glooko's latest funding round?

    Glooko's latest funding round is Series D.

  • How much did Glooko raise?

    Glooko raised a total of $102.5M.

  • Who are Glooko's competitors?

    Competitors of Glooko include BeatO, DIABNEXT, TidePool, Dnurse, Mendor and 14 more.

  • What products does Glooko offer?

    Glooko's products include Glooko Enterprise and 2 more.

  • Who are Glooko's customers?

    Customers of Glooko include University of Michigan and Sharp Rees Steely.

You May Also Like

One Drop Logo
One Drop

One Drop is a consumer digital health company that has developed One Drop. Available for download for iOS and Apple Watch, One Drop harnesses the power of mobile computing and data science to empower people with diabetes to live healthier lives.

WellDoc Logo
WellDoc

WellDoc is a healthcare behavioral science and technology company that focuses on simplifying the way chronic diseases are managed through a collaborative approach that breaks down the barriers of engagement and adherence by providing patients and healthcare providers with real-time information. WellDoc has developed a technology-based solution designed to help people with chronic diseases better manage conditions. The flagship product, DiabetesManager, provides a system for patients and health care providers to coordinate diabetes care, propel self-management and achieve long-term adherence.

InSpark Technologies Logo
InSpark Technologies

Our software provides impactful diabetes management insights at the right time; when people test their blood sugar levels. We can present feedback on undesirable patterns occuring in upcoming problem areas of the day, patterns of glucose variability, risk of hypoglycemia, estimated HbA1c, and insulin sensitivity on monitoring devices or on connected mobile phones.

Emperra Logo
Emperra

Emperra is a startup that creates a digital diabetes management solution. The company's Esysta technology allows the complete capture of all relevant data such as insulin doses, blood sugar levels and carbohydrates.

Omada Health Logo
Omada Health

Omada Health is a digital behavioral medicine company that helps people to change the habits that put them most at risk for serious but largely preventable chronic conditions like heart disease and type 2 diabetes. The company brings behavioral counseling to anyone with an Internet connection, using insights about social networking, gaming, and behavioral science to motivate changes in lifestyle and deliver clinically-meaningful results.

G
Glymetrix

Glymetrix aims to provide engagement strategies to motivate better diabetes management through the use of rewards and incentives. Glymetrix uses a game based interface to engage patients with a data model at the core of the system.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.